Literature DB >> 18097955

Aminopeptidase N (APN)/CD13-dependent CXCR4 downregulation is associated with diminished cell migration, proliferation and invasion.

Jens Wulfaenger1, Susanna Niedling, Dagmar Riemann, Barbara Seliger.   

Abstract

Aminopeptidase N (APN/CD13) is a 150 kDa membrane-bound ubiquitously expressed protease with a broad functional repertoire. It hydrolyzes small peptide mediators, modulates cell motility and adhesion to extracellular matrix and also acts as a viral receptor. In order to dissect the function of enzymatically active and inactive APN/CD13, substitutions of different enzymatic active amino acid residues were generated by site-directed mutagenesis and stably transfected into human embryonic kidney cells. All APN variants analyzed exhibited a complete loss of enzymatic activity, whereas wild type APN transfectants exerted a strong aminopeptidase-specific activity. Furthermore, wild type APN expression was associated with a significant decrease in proliferation, migration and also reduced anchorage-independent growth when compared to enzymatically inactive APN variants and controls. This appeared to be due to a downregulated mRNA and protein expression of the chemokine receptor CXCR4 and an inhibition of the stromal cell-derived factor (SDF)-1alpha/CXCL12-mediated migration. Thus, high APN enzyme activity may antagonize the cellular properties regulated by the CXCR4/SDF-1alpha system in embryonic kidney cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18097955     DOI: 10.1080/09687680701551855

Source DB:  PubMed          Journal:  Mol Membr Biol        ISSN: 0968-7688            Impact factor:   2.857


  15 in total

1.  LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.

Authors:  Jian-Jun Gao; Zu-Hua Gao; Cui-Rong Zhao; Yi Yuan; Shu-Xiang Cui; Xiao-Fan Zhang; Yan-Na Cheng; Wen-Fang Xu; Wei Tang; Xian-Jun Qu
Journal:  Invest New Drugs       Date:  2010-01-29       Impact factor: 3.850

2.  Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.

Authors:  Jianhui Zhu; Jintang He; Yashu Liu; Diane M Simeone; David M Lubman
Journal:  J Proteome Res       Date:  2012-02-28       Impact factor: 4.466

3.  Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues.

Authors:  Paola Di Matteo; Gian Luigi Arrigoni; Luca Alberici; Angelo Corti; Corrado Gallo-Stampino; Catia Traversari; Claudio Doglioni; Gian-Paolo Rizzardi
Journal:  J Histochem Cytochem       Date:  2011-01       Impact factor: 2.479

4.  Mutation of the membrane-associated M1 protease APM1 results in distinct embryonic and seedling developmental defects in Arabidopsis.

Authors:  Wendy Ann Peer; Fazeeda N Hosein; Anindita Bandyopadhyay; Srinivas N Makam; Marisa S Otegui; Gil-Je Lee; Joshua J Blakeslee; Yan Cheng; Boosaree Titapiwatanakun; Bahktiyor Yakubov; Bharat Bangari; Angus S Murphy
Journal:  Plant Cell       Date:  2009-06-16       Impact factor: 11.277

5.  Expression and function of aminopeptidase N/CD13 produced by fibroblast-like synoviocytes in rheumatoid arthritis: role of CD13 in chemotaxis of cytokine-activated T cells independent of enzymatic activity.

Authors:  Rachel Morgan; Judith Endres; Nilofar Behbahani-Nejad; Kristine Phillips; Jeffrey H Ruth; Sean C Friday; Gautam Edhayan; Thomas Lanigan; Andrew Urquhart; Kevin C Chung; David A Fox
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

6.  Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells.

Authors:  Karthikeyan Subbarayan; Sandra Leisz; Claudia Wickenhauser; Daniel Bethmann; Chiara Massa; André Steven; Barbara Seliger
Journal:  Oncoimmunology       Date:  2018-01-16       Impact factor: 8.110

7.  HER-2/neu-mediated down-regulation of biglycan associated with altered growth properties.

Authors:  Christian V Recktenwald; Sandra Leisz; André Steven; Kousaku Mimura; Anja Müller; Jens Wulfänger; Rolf Kiessling; Barbara Seliger
Journal:  J Biol Chem       Date:  2012-05-11       Impact factor: 5.157

8.  Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism.

Authors:  Sandra Leisz; Kristin Schulz; Susanne Erb; Peter Oefner; Katja Dettmer; Dimitrios Mougiakakos; Ena Wang; Francesco M Marincola; Franziska Stehle; Barbara Seliger
Journal:  Oncotarget       Date:  2015-05-10

9.  Mobilized Peripheral Blood versus Cord Blood: Insight into the Distinct Role of Proinflammatory Cytokines on Survival, Clonogenic Ability, and Migration of CD34+ Cells.

Authors:  Dorian Forte; Daria Sollazzo; Martina Barone; Marisole Allegri; Angela di Martella Orsi; Marco Romano; Barbara Sinigaglia; Giuseppe Auteri; Nicola Vianelli; Michele Cavo; Francesca Palandri; Lucia Catani
Journal:  Mediators Inflamm       Date:  2018-07-04       Impact factor: 4.711

10.  Celiac disease microarray analysis based on System Biology Approach.

Authors:  Mostafa Rezaei Tavirani; Davood Bashash; Fatemeh Tajik Rostami; Sina Rezaei Tavirani; Abdolrahim Nikzamir; Majid Rezaei Tavirani; Mohammad Hossain Haidary
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.